In public markets, every investor — from a retail day trader to a billion-dollar fund — receives the same financial disclosures under SEC reporting rules. Quarterly earnings, audited annual filings, material event disclosures: all of it is public and contemporaneous. Pre-IPO secondary investing works almost nothing like this. When you buy a stake in a private company through a secondary transaction, you step into an information environment that is deliberately restricted, contractually tiered, and almost entirely dependent on what the seller chooses to share and what the company chooses to allow.
That asymmetry is not illegal. It is the natural consequence of private company status. But it surprises buyers who approach secondary investing with public-market expectations. This article explains what information rights actually are, who holds them, how they transfer — or fail to transfer — in a secondary transaction, and what a buyer can do to reduce the information gap before committing capital.
What are information rights, and who has them?
Information rights are contractual rights — usually negotiated at the time of an investment — that entitle a shareholder to receive certain financial data from the company. Typical rights include access to audited annual financial statements, unaudited quarterly financials, an annual budget or operating plan, and sometimes the right to inspect the company's books and records on reasonable notice. These rights are usually set out in an investor rights agreement (IRA) or a stockholders' agreement, and they are negotiated, not automatic.
In practice, meaningful information rights are almost exclusively held by institutional investors who participated in primary funding rounds — Series A investors, venture funds, and large strategic investors. These parties negotiated information rights as a condition of writing a check. Common stockholders, including most employees who hold options or restricted stock, typically have no contractual information rights at all. They may receive informal updates, but they have no legal entitlement to audited financials.
Do information rights transfer when shares are sold?
This is the question most secondary buyers fail to ask, and it has a nuanced answer. Under most IRAs and stockholders' agreements, information rights are not automatically transferred when shares change hands. They may be personal to the original investor, subject to a minimum ownership threshold (for example, rights that lapse if the investor falls below 1% of outstanding shares), or explicitly non-transferable without company consent.
Even where the agreement is silent on transfer, companies routinely decline to extend information rights to secondary buyers — particularly individuals or small funds buying through an SPV. The company has no obligation to add a new counterparty to its reporting obligations, and most legal counsel advises keeping the circle of rights-holders narrow ahead of an IPO to reduce Regulation FD (Fair Disclosure) exposure.
The practical result: a buyer who acquires shares expecting to receive quarterly financials may find, after closing, that the company simply does not respond to information requests. The shares are real and the ownership is valid — but the data flow the buyer imagined does not exist.
What a secondary buyer can realistically access
The information landscape for secondary buyers is not completely dark. There are several legitimate channels through which data flows.
- Seller disclosure: The seller can share whatever information they legally possess — and in many jurisdictions, sellers have an obligation not to sell on the basis of material non-public information without disclosure. Asking the seller what they know, and getting their representations in writing, is the most direct information channel a buyer has.
- Public filings and press: Many large private companies file with the SEC under Section 12(g) or Section 15(d) if they exceed shareholder thresholds. Some have issued public debt and file related disclosures. Press coverage, investor letters from public venture funds, and earnings calls from comparable public companies all provide indirect signal.
- 409A valuations: Companies must obtain a third-party 409A valuation — a fair market value appraisal of common stock — at least annually for option grant purposes. Sellers sometimes have access to recent 409A figures. A 409A is not a sale-ready price; it is a floor valuation for tax purposes, typically discounting the common price by 30–60% from the last preferred round price. But it tells you something about where the common stack sits.
- Tender offer documents: If the company has conducted a formal tender offer — where the company or a third party buys back shares from employees at a set price — the offering documents may contain financial summaries. These are not always public but are sometimes available through your seller or through the SEC's EDGAR system if the tender was registered.
- Cap table data services: Third-party data providers aggregate secondary transaction prices and published round data. These are estimates, not audited figures, but they provide pricing context.
SPV structure and information rights: a layered problem
If you are investing through an SPV rather than taking direct shares, the information rights question becomes two-layered. First, does the SPV itself hold shares with any information rights attached? Second, does the SPV agreement give you — as a limited partner or member — the right to receive whatever information the SPV manager receives?
A well-structured SPV will pass through any company-level information rights it holds to its investors, subject to confidentiality obligations. A poorly structured one may give the manager broad discretion to withhold information. Before investing in an SPV, read the operating agreement carefully. Look for provisions covering: reporting obligations of the manager to members, any carve-outs that allow the manager to withhold material information, and the standard of care the manager owes to members in handling non-public data.
Templated SPV documents from a reputable secondary marketplace should address these provisions clearly. If the operating agreement is vague on manager reporting obligations, that is a red flag worth raising before you wire funds.
Representations and warranties in the purchase agreement
Every secondary transaction — direct or SPV-based — should be documented with a purchase and sale agreement that includes representations and warranties from the seller. At minimum, the seller should represent that they have not received notice of ROFR exercise, that the shares are free of liens, that they are not aware of material non-public information that has not been disclosed to the buyer, and that the transfer does not violate any agreement to which the seller is a party.
These representations are your primary legal protection as a buyer in an information-limited environment. They do not give you the financial data you might want — but they do create legal recourse if the seller withheld material facts that later surface. Transactions that close without a proper rep and warranty package expose buyers to significant post-closing risk.
Closing the gap before you commit
The practical approach is not to expect the same disclosures as a public-market investor, but to maximize what is actually available. Request everything the seller can legally share in writing. Review any public filings the company has made. Cross-reference third-party pricing data against the last known preferred round. Read the SPV operating agreement in full, not just the summary. And make sure your purchase agreement contains robust seller representations.
Information-limited does not mean decision-impossible. Investors make sound pre-IPO secondary decisions every day with partial information — but they do it with open eyes, not closed ones. On Limen Markets, our deal documentation includes standardized seller rep packages and SPV operating agreements drafted to address manager reporting obligations. Review the secondary market due diligence checklist on our resources page for a step-by-step walkthrough of what to gather before your indication becomes a commitment.